HEMATOLOGIC OUTCOMES AND DOSING PATTERNS IN ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) SWITCHING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)

被引：0
|
作者：
Hura, Claudia [1 ]
Jackson, James [2 ]
Lunacsek, Orsolya [2 ]
Bailey, Robert A. [3 ]
McKenzie, R. Scott [3 ]
机构：
[1] San Antonio Kidney Dis Ctr, San Antonio, TX USA
[2] Xcenda LLC, Palm Harbor, FL USA
[3] Centocor Ortho Biotech Serv LLC, Horsham, PA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2010年 / 55卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
133
引用
收藏
页码：A65 / A65
页数：1
相关论文
共 50 条
  • [1] OBSERVATIONAL STUDY OF ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) CONVERTING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)
    Lunde, Martin
    Jackson, James
    Lunacsek, Orsolya
    Bailey, Robert A.
    Senbetta, Mekre
    McKenzie, R. Scott
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A60 - A60
  • [2] Epoetin alfa and darbepoetin alfa dosing patterns in anemic pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, RS
    Bookhart, B
    VALUE IN HEALTH, 2006, 9 (03) : A96 - A96
  • [3] Epoetin alfa and darbepoetin alfa dosing trends in pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, S
    Piech, CT
    VALUE IN HEALTH, 2005, 8 (03) : 416 - 416
  • [4] Epoetin alfa and darbepoetin alfa dosing patterns and drug costs in patients with pre-dialysis chronic kidney disease
    Lefevbre, P
    Mody, SH
    McKenzie, RS
    Bookhart, B
    Duh, MS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A39 - A39
  • [5] Hospital inpatient utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in patients with cancer and pre-dialysis chronic kidney disease (PCKD)
    Smith, J
    He, J
    Mahoney, A
    Noone, P
    Watson, S
    Mody, S
    McKenzie, RS
    VALUE IN HEALTH, 2006, 9 (03) : A105 - A105
  • [6] Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa
    Hymes, Jeffrey
    Bickimer, Tammy
    Jackson, James H.
    Bookhart, Brahim K.
    Mody, Samir H.
    Piech, Catherine Tak
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (08) : 1931 - 1937
  • [7] Epoetin alfa and darbepoetin alfa dosing trends and drug costs in elderly pre-dialysis chronic kidney disease patients
    Mody, S.
    Padmanabhan, V
    Bookhart, B.
    Mckenzie, R. S.
    VALUE IN HEALTH, 2007, 10 (03) : A12 - A13
  • [8] Alternate dosing strategies of epoetin alfa in pre-dialysis chronic kidney disease patients.
    Sarac, E
    Smavatkul, C
    Boolchand, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 794A - 794A
  • [9] The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease
    Cremieux, Pierre-Yves
    Van Audenrode, Marc
    Lefebvre, Patrick
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (12) : 2329 - 2336
  • [10] EPOETIN ALFA AND DARBEPOETIN ALFA COSTS BY DOMINANT DOSING INTERVAL IN CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
    Bailey, Robert
    Tunceli, Ozgur
    Singer, Joseph
    Stephenson, Judith
    Senbetta, Mekre
    McKenzie, Scott
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A23 - A23
12345